News & Updates

Show Multimedia Only

Auricular vagus nerve stimulation of little benefit in rheumatoid arthritis

19 Dec 2023

Auricular vagus nerve stimulation (VNS) does not appear to be efficacious at managing disease activity in individuals with rheumatoid arthritis, as reported in a study.

Auricular vagus nerve stimulation of little benefit in rheumatoid arthritis

19 Dec 2023

$Blood cadmium may signal osteoporosis-related fractures among never-smokers$

Blood cadmium may signal osteoporosis-related fractures among never-smokers

15 Dec 2023

Increased concentrations of cadmium in the blood are associated with a heightened risk of developing osteoporosis-related fractures among individuals who have never smoked, according to a study.

Blood cadmium may signal osteoporosis-related fractures among never-smokers

15 Dec 2023

Sleep problems pester patients with psoriatic arthritis

12 Dec 2023

Patients with psoriatic arthritis (PsA) often struggle with poor sleep quality, results of a systematic review and meta-analysis have shown.

Sleep problems pester patients with psoriatic arthritis

12 Dec 2023

Obesity persists in axSpA, especially in socially deprived patients

11 Dec 2023

Obesity appears to be prevalent among patients with axial spondyloarthritis (axSpA) compared to the general population, according to a Swiss study, noting that socially disadvantaged individuals are most affected by this comorbidity.

Obesity persists in axSpA, especially in socially deprived patients

11 Dec 2023

JAK inhibitors shown safe, effective in RA patients

11 Dec 2023

A recent study has demonstrated the safety and efficacy of oral Janus kinase (JAK) inhibitors in patients with rheumatoid arthritis (RA) in the real-world setting, particularly in those who do not present with cardiovascular risk factors at baseline.

JAK inhibitors shown safe, effective in RA patients

11 Dec 2023

Severe nonadherence to hydroxychloroquine for lupus may have adverse consequences

07 Dec 2023

Among patients receiving hydroxychloroquine for systemic lupus erythematosus (SLE), severe nonadherence to medication poses increased risks of SLE flare in the following year, early damage, and 5-year mortality, according to data from the SLICC* Inception Cohort.

Severe nonadherence to hydroxychloroquine for lupus may have adverse consequences

07 Dec 2023

Low-dose methotrexate may pose serious adverse event risk for older adults with CKD

05 Dec 2023 by

For older adults with chronic kidney disease (CKD) who are initiating a disease-modifying antirheumatic drug (DMARD), low-dose methotrexate appears to be associated with a heightened 90-day risk of serious adverse events compared with hydroxychloroquine, as shown in a study.

Low-dose methotrexate may pose serious adverse event risk for older adults with CKD

05 Dec 2023

Inflammation, disease duration and delayed diagnosis associated with hypertension in axial spondyloarthritis

05 Dec 2023 by

Axial spondyloarthritis (axSpA) patients with a higher inflammatory burden, longer delay in diagnosis and longer baseline disease duration (BLDD) have an increased risk of developing incident hypertension after adjusting for traditional cardiovascular (CV) risk factors, a retrospective cohort study by the Chinese University of Hong Kong has shown.

Inflammation, disease duration and delayed diagnosis associated with hypertension in axial spondyloarthritis

05 Dec 2023

Avacopan beneficial in ANCA-related vasculitis patients on rituximab

02 Dec 2023

Avacopan, when added to background induction therapy with rituximab, is as efficacious as a prednisone taper in terms of inducing remission at week 26 and is associated with a higher rate of sustained remission at week 52 in patients with antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis, according to the phase III ADVOCATE trial.

Avacopan beneficial in ANCA-related vasculitis patients on rituximab

02 Dec 2023

Remibrutinib for Sjögren’s syndrome impresses in phase II trial

16 Nov 2023

The selective potent oral BTK inhibitor remibrutinib has shown favourable efficacy and safety in the treatment of patients with Sjögren’s syndrome, according to the results of a phase II trial.

Remibrutinib for Sjögren’s syndrome impresses in phase II trial

16 Nov 2023

News & Updates

Showing Rheumatology articles

Showing

Specialty:

Auricular vagus nerve stimulation of little benefit in rheumatoid arthritis

Auricular vagus nerve stimulation of little benefit in rheumatoid arthritis

Blood cadmium may signal osteoporosis-related fractures among never-smokers

Blood cadmium may signal osteoporosis-related fractures among never-smokers

Sleep problems pester patients with psoriatic arthritis

Sleep problems pester patients with psoriatic arthritis

Obesity persists in axSpA, especially in socially deprived patients

Obesity persists in axSpA, especially in socially deprived patients

JAK inhibitors shown safe, effective in RA patients

JAK inhibitors shown safe, effective in RA patients

Severe nonadherence to hydroxychloroquine for lupus may have adverse consequences

Severe nonadherence to hydroxychloroquine for lupus may have adverse consequences

Low-dose methotrexate may pose serious adverse event risk for older adults with CKD

Low-dose methotrexate may pose serious adverse event risk for older adults with CKD

Inflammation, disease duration and delayed diagnosis associated with hypertension in axial spondyloarthritis

Inflammation, disease duration and delayed diagnosis associated with hypertension in axial spondyloarthritis

Avacopan beneficial in ANCA-related vasculitis patients on rituximab

Avacopan beneficial in ANCA-related vasculitis patients on rituximab

Remibrutinib for Sjögren’s syndrome impresses in phase II trial

Remibrutinib for Sjögren’s syndrome impresses in phase II trial